As part of the United Kingdom\u2019s national action plan for antimicrobial (AMR) resistance, NHS England and NHS Improvement\u2019s AMR programme is examining the adoption of innovations in diagnostics, improving clinical best practice and applying point-of-care testing for urinary tract infections, respiratory tract infections, surgical site infections and acute deterioration, including sepsis.<\/p>
This aims to identify any gaps in diagnostic pathways and practices with a focus on improving patient outcomes and antimicrobial stewardship in National Health Service and community care settings. Optimising the potential use of point-of-care multiplex testing in primary care is also being considered. NHS England and NHS Improvement supports the appointment of diagnostics and antimicrobial stewardship leads in each regional team in England. Additionally, national guidelines and national toolkits such as TARGET in primary care and \u2018Start SMART then focus\u2019 in secondary care, support antimicrobial stewardship, including the appropriate use of diagnostic tests and tools.<\/p>
<\/strong><\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4447", "label" : {"_value" : "Biography information for Maggie Throup"}
}
, "answeringMemberConstituency" : {"_value" : "Erewash"}
, "answeringMemberPrinted" : {"_value" : "Maggie Throup"}
, "dateOfAnswer" : {"_value" : "2022-05-26", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : [{"_value" : "4630"}
, {"_value" : "4631"}
], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2022-05-26T15:36:52.933Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2022-05-18", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Antimicrobials: Drug Resistance"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, with reference to the 2016 Review on Antimicrobial Resistance: Lord O\u2019Neill\u2019s independent review of antimicrobial resistance in collaboration with the Wellcome Trust, which recommended that all antibiotic prescribing should be informed by rapid diagnostics, what steps he is taking to ensure that primary care settings are equipped with point of care multiplex testing technology.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4474", "label" : {"_value" : "Biography information for Kevin Hollinrake"}
}
, "tablingMemberConstituency" : {"_value" : "Thirsk and Malton"}
, "tablingMemberPrinted" : [{"_value" : "Kevin Hollinrake"}
], "uin" : "4632"}
, {"_about" : "http://data.parliament.uk/resources/1464023", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1464023/answer", "answerText" : {"_value" : " The United Kingdom\u2019s antimicrobial national action plan aims to reduce the need for and unintentional exposure to antimicrobials by lowering the burden of infection; optimise the use of antimicrobials; and invest in innovation, supply and access of new diagnostics, therapies and vaccines.<\/p> Diagnostics and antimicrobial stewardship leads have been appointed in NHS England regional teams and national toolkits, decision aids and guidelines to support the appropriate use of antimicrobials have been developed and published. Commissioning for Quality and Innovation schemes for management of urinary tract infection and reducing antimicrobial use in secondary care have also been implemented.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4447", "label" : {"_value" : "Biography information for Maggie Throup"}
}
, "answeringMemberConstituency" : {"_value" : "Erewash"}
, "answeringMemberPrinted" : {"_value" : "Maggie Throup"}
, "dateOfAnswer" : {"_value" : "2022-05-26", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2022-05-26T14:59:51.647Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2022-05-18", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Antimicrobials: Drug Resistance"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, with reference to the report published by his Department entitled Tackling antimicrobial resistance 2019\u20132024: the UK's 5-year national action plan, published on 24 January 2019, whether his Department is taking steps to (a) tackle the growing threat of antimicrobial resistance and (b) embed support for antimicrobial stewardship in his Department's work.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4474", "label" : {"_value" : "Biography information for Kevin Hollinrake"}
}
, "tablingMemberConstituency" : {"_value" : "Thirsk and Malton"}
, "tablingMemberPrinted" : [{"_value" : "Kevin Hollinrake"}
], "uin" : "4633"}
, {"_about" : "http://data.parliament.uk/resources/997217", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/997217/answer", "answerText" : {"_value" : " Infection prevention and control will remain a key pillar of the United Kingdom\u2019s upcoming five-year national action plan on antimicrobial resistance.<\/p> <\/p> NHS Improvement, who lead on infection prevention and control, has included a hand hygiene monitoring and compliance workstream in its current work programme.<\/p> <\/p> NHS Improvement has undertaken a rapid review of evidence on the use of electronic monitoring devices across the National Health Service to determine hand hygiene compliance. The technology used in some trusts is currently reliant on local data infrastructure and many existing systems would not be able to support it.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"}
}
, "answeringMemberConstituency" : {"_value" : "Winchester"}
, "answeringMemberPrinted" : {"_value" : "Steve Brine"}
, "dateOfAnswer" : {"_value" : "2018-11-06", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2018-11-06T15:31:20.87Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2018-10-29", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Antimicrobials: Drug Resistance"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 16 March 2018 to Question 132264 on Antibiotics: Drug Resistance, whether his Department has made an assessment of the potential merits of including (a) the latest electronic technology to reduce hospital infections and (b) other best practice on hand hygiene compliance in the prevention strand of the new antimicrobial resistance strategy.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4474", "label" : {"_value" : "Biography information for Kevin Hollinrake"}
}
, "tablingMemberConstituency" : {"_value" : "Thirsk and Malton"}
, "tablingMemberPrinted" : [{"_value" : "Kevin Hollinrake"}
], "uin" : "185000"}
, {"_about" : "http://data.parliament.uk/resources/861115", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/861115/answer", "answerText" : {"_value" : " The current five year United Kingdom Antimicrobial Resistance (AMR) strategy was published at the end of 2013. Work is underway to consider the priorities and focus for a refreshed strategy and national action plan for publication at the end of 2018. The refreshed strategy will continue to focus on preventing infections as one of its key pillars.<\/p> <\/p> The current AMR programme has an ambition to halve healthcare associated Gram\u2013negative blood stream infections by 2020/2021. NHS Improvement leads this work and has included hand hygiene in its work programme for 2018/19 in support of the ambition. As part of our work on the refreshed strategy, we will consider how to make best use of evidence-based and cost-effective technology.<\/p> <\/p> We are working with our partners across the health and social care system, including the Care Quality Commission, to ensure that consideration of best practice in hand hygiene policies remains a focus of inspections in acute trusts.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"}
}
, "answeringMemberConstituency" : {"_value" : "Winchester"}
, "answeringMemberPrinted" : {"_value" : "Steve Brine"}
, "dateOfAnswer" : {"_value" : "2018-03-16", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : {"_value" : "132266"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2018-03-16T11:42:43.93Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2018-03-13", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Antimicrobials: Drug Resistance"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, when his Department plans to publish a new five year AMR Strategy, and whether that strategy will include best practice on infection prevention and control, including hand hygiene compliance.", "registeredInterest" : {"_value" : "true", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4474", "label" : {"_value" : "Biography information for Kevin Hollinrake"}
}
, "tablingMemberConstituency" : {"_value" : "Thirsk and Malton"}
, "tablingMemberPrinted" : [{"_value" : "Kevin Hollinrake"}
], "uin" : "132264"}
, {"_about" : "http://data.parliament.uk/resources/861117", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/861117/answer", "answerText" : {"_value" : " The current five year United Kingdom Antimicrobial Resistance (AMR) strategy was published at the end of 2013. Work is underway to consider the priorities and focus for a refreshed strategy and national action plan for publication at the end of 2018. The refreshed strategy will continue to focus on preventing infections as one of its key pillars.<\/p> <\/p> The current AMR programme has an ambition to halve healthcare associated Gram\u2013negative blood stream infections by 2020/2021. NHS Improvement leads this work and has included hand hygiene in its work programme for 2018/19 in support of the ambition. As part of our work on the refreshed strategy, we will consider how to make best use of evidence-based and cost-effective technology.<\/p> <\/p> We are working with our partners across the health and social care system, including the Care Quality Commission, to ensure that consideration of best practice in hand hygiene policies remains a focus of inspections in acute trusts.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"}
}
, "answeringMemberConstituency" : {"_value" : "Winchester"}
, "answeringMemberPrinted" : {"_value" : "Steve Brine"}
, "dateOfAnswer" : {"_value" : "2018-03-16", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : {"_value" : "132264"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2018-03-16T11:42:43.977Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2018-03-13", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Antimicrobials: Drug Resistance"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what steps his Department is taking to improve hand hygiene compliance in hospitals to tackle antimicrobial resistance; and what assessment his Department has made of the potential merits of using health technology to improve such compliance.", "registeredInterest" : {"_value" : "true", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4474", "label" : {"_value" : "Biography information for Kevin Hollinrake"}
}
, "tablingMemberConstituency" : {"_value" : "Thirsk and Malton"}
, "tablingMemberPrinted" : [{"_value" : "Kevin Hollinrake"}
], "uin" : "132266"}
, {"_about" : "http://data.parliament.uk/resources/714582", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/714582/answer", "answerText" : {"_value" : " The Government has committed £50 million towards setting up a Global Antimicrobial Resistance (AMR) Innovation Fund to increase global investment in AMR. The fund aims to leverage substantial new international investment in AMR research and development for new and repurposed antimicrobials and alternative medicines, rapid diagnostic tests, vaccines and other important technologies, interventions and therapies.<\/p> Professor Dame Sally Davies, the Chief Medical Officer for England and United Kingdom Government adviser, has appointed an expert advisory board to make recommendations on the scope and focus of the investment.<\/p> These discussions are ongoing.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4019", "label" : {"_value" : "Biography information for Baroness Blackwood of North Oxford"}
}
, "answeringMemberConstituency" : {"_value" : "Oxford West and Abingdon"}
, "answeringMemberPrinted" : {"_value" : "Nicola Blackwood"}
, "dateOfAnswer" : {"_value" : "2017-04-05", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2017-04-05T10:00:27.467Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2017-03-28", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Antimicrobials: Drug Resistance"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, when he expects the Global Antimicrobial Resistance Innovation Fund to be open to research applications for the repurposing of antibiotics.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4474", "label" : {"_value" : "Biography information for Kevin Hollinrake"}
}
, "tablingMemberConstituency" : {"_value" : "Thirsk and Malton"}
, "tablingMemberPrinted" : [{"_value" : "Kevin Hollinrake"}
], "uin" : "69526"}
, {"_about" : "http://data.parliament.uk/resources/714584", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/714584/answer", "answerText" : {"_value" : " The Global Antimicrobial Resistance (AMR) Innovation Fund is a £50 million investment over five years to tackle AMR, with the aim of attracting significant additional investment internationally to stimulate global research. It is not looking at reimbursement models to incentivise the development of new classes of antibiotics or planning to fund pilots at this stage.<\/p> Domestically, the Department is working with the National Institute for Health and Care Excellence and the Association of the British Pharmaceutical Industry to develop a new reimbursement model for antimicrobials, and has secured broad agreement to principles that would permit a model to \u2018de-link\u2019 company revenues from sales. The aim of this work is to support good antimicrobial stewardship. Discussions with a number of leading pharmaceutical companies have highlighted challenges in evaluating antimicrobial medicines, and the Department is working closely with industry partners to address these.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4019", "label" : {"_value" : "Biography information for Baroness Blackwood of North Oxford"}
}
, "answeringMemberConstituency" : {"_value" : "Oxford West and Abingdon"}
, "answeringMemberPrinted" : {"_value" : "Nicola Blackwood"}
, "dateOfAnswer" : {"_value" : "2017-04-05", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2017-04-05T10:24:11.15Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2017-03-28", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Antimicrobials: Drug Resistance"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, when he expects the first pilots of the Global Antimicrobial Resistance Innovation Fund on reimbursement models to incentivise the development of new classes of antibiotics to begin.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4474", "label" : {"_value" : "Biography information for Kevin Hollinrake"}
}
, "tablingMemberConstituency" : {"_value" : "Thirsk and Malton"}
, "tablingMemberPrinted" : [{"_value" : "Kevin Hollinrake"}
], "uin" : "69527"}
, {"_about" : "http://data.parliament.uk/resources/536471", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/536471/answer", "answerText" : {"_value" : " Antimicrobial resistance (AMR) is growing, presenting huge costs to both society and the global economy \u2013 it is estimated that AMR will have a cumulative cost of $100 trillion by 2050. One of the main issues driving the increase in AMR is a market failure preventing enough new antibiotic drugs from getting to market. The United Kingdom sees the G20 as the best forum to discuss this economic issue and take action. The UK is calling for the G20 to look at how it can put in place innovative financing mechanisms to reinvigorate the antimicrobial development pipeline and help rectify this market failure.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4019", "label" : {"_value" : "Biography information for Baroness Blackwood of North Oxford"}
}
, "answeringMemberConstituency" : {"_value" : "Oxford West and Abingdon"}
, "answeringMemberPrinted" : {"_value" : "Nicola Blackwood"}
, "dateOfAnswer" : {"_value" : "2016-07-19", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2016-07-19T13:46:45.8Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2016-07-14", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Antimicrobials: Drug Resistance"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, what role he plans for the UK in discussing antimicrobial resistance at the G20 summit in September 2016.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4474", "label" : {"_value" : "Biography information for Kevin Hollinrake"}
}
, "tablingMemberConstituency" : {"_value" : "Thirsk and Malton"}
, "tablingMemberPrinted" : [{"_value" : "Kevin Hollinrake"}
], "uin" : "42800"}
], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 8, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]}
}